Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals

European Journal of Immunology

Volumn 45, Issue 2, 2015, Pages 492-500

  Cassidy, Sorcha ^a,b   Mukherjee, Sayak ^c   Myint, Thet Mon ^d   Mbiribindi, Berenice ^a   North, Helen ^d   Traherne, James ^e   Mulder, Arend ^f   Claas, Frans Hj ^f   Purbhoo, Marco A ^b   Das, Jayajit ^c,g   Khakoo, Salim I ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

Killer cell immunoglobulin like receptors; MHC class I; Natural killer cells; Peptide; Peptide selectivity

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PEPTIDE DERIVATIVE; HLA C ANTIGEN; KIR2DL2 PROTEIN, HUMAN; KIR2DL3 PROTEIN, HUMAN; LIGAND; PEPTIDE; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; DEGRANULATION; GENE FREQUENCY; GENOTYPE; HLA SYSTEM; HOMOZYGOTE; HUMAN; HUMAN CELL; INVESTIGATIVE PROCEDURES; MATHEMATICAL MODEL; NATURAL KILLER CELL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; AMINO ACID SEQUENCE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PRIMARY CELL CULTURE; STATISTICAL MODEL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; CELL DEGRANULATION; GENE EXPRESSION REGULATION; GENOTYPE; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MODELS, STATISTICAL; MOLECULAR SEQUENCE DATA; PEPTIDES; PRIMARY CELL CULTURE; PROTEIN BINDING; RECEPTORS, KIR2DL2; RECEPTORS, KIR2DL3; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84922981771     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444613     Document Type: Article

References (32)

1. Crome, S. Q., Lang, P. A., Lang, K. S. and Ohashi, P. S., Natural killer cells regulate diverse T cell responses. Trends Immunol. 2013. 34: 342-349.
2. Moretta, A., The dialogue between human natural killer cells and dendritic cells. Curr. Opin. Immunol. 2005. 17: 306-311.
3. Long, E. O., Kim, H. S., Liu, D., Peterson, M. E. and Rajagopalan, S., Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 2013. 31: 227-258.
4. Lanier, L. L., Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008. 9: 495-502.
5. Long, E. O., Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008. 224: 70-84.
6. Parham, P. and Moffett, A., Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 2013. 13: 133-144.
7. Kulkarni, S., Martin, M. P. and Carrington, M., The Yin and Yang of HLA and KIR in human disease. Semin. Immunol. 2008. 20: 343-352.
8. Jamil, K. M. and Khakoo, S. I., KIR/HLA interactions and pathogen immunity. J. Biomed. Biotechnol. 2011. 2011: 298348.
9. Ahlenstiel, G., Martin, M. P., Gao, X., Carrington, M. and Rehermann, B., Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J. Clin. Invest. 2008. 118: 1017-1026.
10. Moesta, A. K. and Parham, P., Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol. 2012. 3: 336.
11. Alter, G. and Altfeld, M., NK cell function in HIV-1 infection. Curr. Mol. Med. 2006. 6: 621-629.
12. Tiemessen, C. T., Paximadis, M., Minevich, G., Winchester, R., Shalekoff, S., Gray, G. E., Sherman, G. G. et al., Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. J. Acquir. Immune Defic. Syndr. 2011. 57: 181-189.
13. Hirayasu, K., Ohashi, J., Kashiwase, K., Hananantachai, H., Naka, I., Ogawa, A., Takanashi, M. et al., Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA. PLoS Pathog. 2012. 8: e1002565.
14. Martin, M. P., Nelson, G., Lee, J. H., Pellett, F., Gao, X., Wade, J., Wilson, M. J. et al., Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 2002. 169: 2818-2822.
15. Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J. et al., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004. 305: 872-874.
16. Romero, V., Azocar, J., Zuniga, J., Clavijo, O. P., Terreros, D., Gu, X., Husain, Z. et al., Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol. Immunol. 2008. 45: 2429-2436.
17. Vidal-Castineira, J. R., Lopez-Vazquez, A., Diaz-Pena, R., Alonso-Arias, R., Martinez-Borra, J., Perez, R., Fernandez-Suarez, J. et al., Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J. Virol. 2010. 84: 475-481.
18. Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M. and Parham, P., Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 2008. 180: 3969-3979.
19. Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O. and Wagtmann, N., Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 1998. 161: 571-577.
20. Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G. and Sun, P. D., Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000. 405: 537-543.
21. Maenaka, K., Juji, T., Nakayama, T., Wyer, J. R., Gao, G. F., Maenaka, T., Zaccai, N. R. et al., Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 1999. 274: 28329-28334.
22. Vales-Gomez, M., Reyburn, H. T., Erskine, R. A. and Strominger, J., Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc. Natl. Acad. Sci. USA 1998. 95: 14326-14331.
23. Fadda, L., Borhis, G., Ahmed, P., Cheent, K., Pageon, S. V., Cazaly, A., Stathopoulos, S. et al., Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. USA 2010. 107: 10160-10165.
24. Borhis, G., Ahmed, P. S., Mbiribindi, B., Naiyer, M. M., Davis, D. M., Purbhoo, M. A. and Khakoo, S. I., A peptide antagonist disrupts NK cell inhibitory synapse formation. J. Immunol. 2013. 190: 2924-2930.
25. Barber, L. D., Percival, L., Valiante, N. M., Chen, L., Lee, C., Gumperz, J. E., Phillips, J. H. et al., The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C. J. Exp. Med. 1996. 184: 735-740.
26. Yewdell, J. W., Reits, E. and Neefjes, J., Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 2003. 3: 952-961.
27. Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W. and Bennink, J. R., Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000. 404: 770-774.
28. Yewdell, J. W., DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol. 2011. 32: 548-558.
29. Croft, N. P., Smith, S. A., Wong, Y. C., Tan, C. T., Dudek, N. L., Flesch, I. E., Lin, L. C. et al., Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog 2013. 9: e1003129.
30. Liu, J., Xiao, Z., Ko, H. L., Shen, M. and Ren, E. C., Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11. Proc. Natl. Acad. Sci. USA 2014. 111: 2662-2667.
31. David, G., Djaoud, Z., Willem, C., Legrand, N., Rettman, P., Gagne, K., Cesbron, A. and Retiere, C., Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. J. Immunol. 2013. 191: 4778-4788.
32. Jiang, W., Johnson, C., Jayaraman, J., Simecek, N., Noble, J., Moffatt, M. F., Cookson, W. O. et al., Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res. 2012. 22: 1845-1854.